585 related articles for article (PubMed ID: 15844071)
1. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
Weiner M; Benator D; Burman W; Peloquin CA; Khan A; Vernon A; Jones B; Silva-Trigo C; Zhao Z; Hodge T;
Clin Infect Dis; 2005 May; 40(10):1481-91. PubMed ID: 15844071
[TBL] [Abstract][Full Text] [Related]
2. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Li J; Munsiff SS; Driver CR; Sackoff J
Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
Benator DA; Weiner MH; Burman WJ; Vernon AA; Zhao ZA; Khan AE; Jones BE; Sandman L; Engle M; Silva-Trigo C; Hsyu PH; Becker MI; Peloquin CA;
Pharmacotherapy; 2007 Jun; 27(6):793-800. PubMed ID: 17542762
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis.
Boulanger C; Hollender E; Farrell K; Stambaugh JJ; Maasen D; Ashkin D; Symes S; Espinoza LA; Rivero RO; Graham JJ; Peloquin CA
Clin Infect Dis; 2009 Nov; 49(9):1305-11. PubMed ID: 19807276
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use.
Nettles RE; Mazo D; Alwood K; Gachuhi R; Maltas G; Wendel K; Cronin W; Hooper N; Bishai W; Sterling TR
Clin Infect Dis; 2004 Mar; 38(5):731-6. PubMed ID: 14986259
[TBL] [Abstract][Full Text] [Related]
6. Rifamycin-resistant Mycobacterium tuberculosis in the highly active antiretroviral therapy era: a report of 3 relapses with acquired rifampin resistance following alternate-day rifabutin and boosted protease inhibitor therapy.
Jenny-Avital ER; Joseph K
Clin Infect Dis; 2009 May; 48(10):1471-4. PubMed ID: 19368504
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.
Holland DP; Hamilton CD; Weintrob AC; Engemann JJ; Fortenberry ER; Peloquin CA; Stout JE
Pharmacotherapy; 2009 May; 29(5):503-10. PubMed ID: 19397460
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis.
Weiner M; Benator D; Peloquin CA; Burman W; Vernon A; Engle M; Khan A; Zhao Z;
Clin Infect Dis; 2005 Nov; 41(9):1343-9. PubMed ID: 16206114
[TBL] [Abstract][Full Text] [Related]
9. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(10):214-5. PubMed ID: 11922192
[TBL] [Abstract][Full Text] [Related]
10. Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis.
Burman W; Benator D; Vernon A; Khan A; Jones B; Silva C; Lahart C; Weis S; King B; Mangura B; Weiner M; El-Sadr W;
Am J Respir Crit Care Med; 2006 Feb; 173(3):350-6. PubMed ID: 16109981
[TBL] [Abstract][Full Text] [Related]
11. Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine.
Weiner M; Burman W; Vernon A; Benator D; Peloquin CA; Khan A; Weis S; King B; Shah N; Hodge T;
Am J Respir Crit Care Med; 2003 May; 167(10):1341-7. PubMed ID: 12531776
[TBL] [Abstract][Full Text] [Related]
12. Does AIDS impair the absorption of antituberculosis agents?
Taylor B; Smith PJ
Int J Tuberc Lung Dis; 1998 Aug; 2(8):670-5. PubMed ID: 9712282
[TBL] [Abstract][Full Text] [Related]
13. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
[TBL] [Abstract][Full Text] [Related]
14. Drugs for tuberculosis.
Treat Guidel Med Lett; 2004 Dec; 2(28):83-8. PubMed ID: 15557876
[No Abstract] [Full Text] [Related]
15. Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.
Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G
J Infect; 2008 Jul; 57(1):78-81. PubMed ID: 18550175
[TBL] [Abstract][Full Text] [Related]
16. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
17. Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy.
Naiker S; Connolly C; Wiesner L; Kellerman T; Reddy T; Harries A; McIlleron H; Lienhardt C; Pym A
BMC Pharmacol Toxicol; 2014 Nov; 15():61. PubMed ID: 25406657
[TBL] [Abstract][Full Text] [Related]
18. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
[TBL] [Abstract][Full Text] [Related]
19. Acquired rifamycin resistance: pharmacology and biology.
Wallis RS; Weyer K; Fourie PB
Expert Rev Anti Infect Ther; 2008 Apr; 6(2):223-30. PubMed ID: 18380604
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with reduced antituberculous serum drug concentrations in patients with HIV-TB coinfection.
Ahmed R; Cooper R; Foisy M; Der E; Kunimoto D
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(5):273-6. PubMed ID: 22875581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
